FFND vs. PBE ETF Comparison

Comparison of The Future Fund Active ETF (FFND) to PowerShares Dynamic Biotech & Genome (PBE)
FFND

The Future Fund Active ETF

FFND Description

Northern Lights Fund Trust II - The Future Fund Active ETF is an exchange traded fund launched by Northern Lights Fund Trust II. The fund is managed by The Future Fund, LLC. It invests in public equity markets of the United States. The fund invests directly, through derivatives and through other funds in stocks of companies operating across diversified sectors. It employs long/short strategy and uses derivatives such as futures and options to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It employs proprietary research to create its portfolio. Northern Lights Fund Trust II - The Future Fund Active ETF was formed on August 24, 2021 and is domiciled in the United States. The investment seeks to provide capital appreciation. Under normal market conditions, the fund, which is an actively managed ETF, will primarily invest in the equity securities of companies that the adviser believes to be best positioned to take advantage of or profit from emerging technological or social trends or developments.

Grade (RS Rating)

Last Trade

$22.30

Average Daily Volume

2,613

Number of Holdings *

34

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$64.06

Average Daily Volume

17,493

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
Period FFND PBE
30 Days -1.76% 1.23%
60 Days -0.29% -3.98%
90 Days 9.84% -0.07%
12 Months 37.95% 2.88%
2 Overlapping Holdings
Symbol Grade Weight in FFND Weight in PBE Overlap
HALO D 3.5% 3.09% 3.09%
VRTX D 1.96% 5.04% 1.96%
FFND Overweight 32 Positions Relative to PBE
Symbol Grade Weight
GOOGL A 10.12%
NVDA C 5.43%
LLY D 4.67%
CMG A 3.99%
GTLS C 3.96%
ABNB D 3.92%
UBER D 3.5%
CRM D 3.37%
GPRE F 3.11%
NFLX D 3.05%
KTOS B 2.95%
CELH D 2.91%
LULU F 2.82%
TSLA D 2.79%
LPLA A 2.74%
SCHW A 2.5%
DASH D 2.47%
ONON C 2.24%
FTI A 2.16%
GTLB F 2.14%
ZTS D 2.13%
WOLF F 1.96%
EW D 1.87%
ASML D 1.67%
PANW B 1.67%
MU B 1.47%
CIEN D 1.45%
BIDU C 1.39%
RIVN F 1.29%
PWR A 1.16%
EXAS F 1.06%
YNDX C 0.62%
FFND Underweight 28 Positions Relative to PBE
Symbol Grade Weight
NBIX A -5.53%
BMRN F -5.43%
AMGN A -5.05%
REGN B -5.01%
GILD F -4.87%
TECH C -4.74%
BIIB D -4.61%
MNKD D -3.3%
EXEL D -3.22%
COLL C -3.2%
UTHR A -3.12%
TGTX C -3.08%
CPRX D -3.05%
BPMC A -2.89%
ITCI C -2.87%
CLDX C -2.8%
PTCT B -2.79%
QGEN C -2.79%
DVAX D -2.73%
IONS F -2.69%
VCEL C -2.68%
RGEN D -2.45%
XENE C -2.42%
MYGN D -2.26%
VCYT D -2.26%
FOLD F -2.23%
ACAD F -1.92%
EYPT D -1.81%
Compare ETFs